Consistent with our findings, Beird et al. demonstrated that the plasmacytoid dendritic cell markers CCDC50 and LAMP5 were significantly more highly expressed in BPDCN than in AML, as revealed by transcriptome microarray analysis [30]. The gene discussed is CCDC50; the disease is acute myeloid leukemia.